Cytomegalovirus infection in patients with systemic lupus erythematosus

Clinical and Experimental Rheumatology

Volumn 20, Issue 4, 2002, Pages 559-564

  Sekigawa, Iwao ^a   Nawata, M ^a   Seta, N ^a   Yamada, M ^a   Iida, N ^a   Hashimoto, H ^a  

^a JUNTENDO UNIVERSITY SHIZUOKA HOSPITAL   (Japan)

Author keywords

Human cytomegalovirus; Opportunitic infection; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; GANCICLOVIR; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; ANTIVIRUS AGENT; GLUCOCORTICOID; VIRUS ANTIGEN; VIRUS DNA;

AUTOIMMUNE DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; ADOLESCENT; ADULT; AGED; CHILD; CYTOMEGALIC INCLUSION BODY DISEASE; FEMALE; GENETICS; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTION; PATHOLOGY;

ADOLESCENT; ADULT; AGED; ANTIGENS, VIRAL; ANTIVIRAL AGENTS; CHILD; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; FEMALE; GLUCOCORTICOIDS, SYNTHETIC; HUMAN; IMMUNOGLOBULINS, INTRAVENOUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGE; OPPORTUNISTIC INFECTIONS; GLUCOCORTICOIDS; HUMANS; MIDDLE AGED;

EID: 0035988642     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Infection in systemic lupus erythematosus
2. Systemic lupus erythematosus - Is a viral aetiology a credible hypothesis?
3. Retroviruses and autoimmunity
4. Quantitative analyses of messenger RNA of human endogenous retrovirus in SLE patients
5. Human parvovirus B19 infection resembling systemic lupus erythematosus
6. Potential role of the Epstein-Barr virus in systemic lupus erythematosus autoimmunity
7. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure
8. Concomitant alveolar haemorrhage and cytomegalovirus infection in a patient with systemic lupus erythematosus
9. Systemic lupus erythematosus and concurrent cytomegalovirus vasculitis: Diagnosis by antemortem skin biopsy
10. Cytomegalovirus-induced flare of systemic lupus erythematosus
11. Fatal intestinal pneumonia due to cytomegalovirus following cyclophosphamide treatment in a patient with systemic lupus erythematosus
12. Disseminated cytomegalovirus disease in a patient with systemic lupus erythematosus not undergoing immunosuppressive therapy
13. Acute cytomegalovirus hepatitis with systemic lupus erythematosus
14. Thrombocytopenia in systemic lupus erythematosus associated with cytomegalovirus infection
15. Exacerbation of systemic lupus erythematosus related to cytomegalovirus infection
16. Possible triggering effect of cytomegalovirus infection on systemic lupus erythematosus
17. Comparison between viremia and antigenemia for detection of cytomegalovirus in blood
18. Human cytomegalovirus infection and systemic lupus erythematosus
19. Correlation between cytomegalovirus infection and Raynaud's phenomenon in lupus nephritis
20. A longitudinal study of human cytomegalovirus serology and viruria fails to detect active viral infection in 20 systemic lupus erythematosus patients
21. Rises in antidouble stranded DNA antibody levels prior to exacerbations of systemic lupus erythematosus are not merely due to polyclonal B cell activation
22. A unifying concept of viral immunopathogenesis of proliferative and aproliferative diseases (working hypothesis)
23. Specificity of antibody responses affected by extracorporeal immunoadsorption of plasma over columns of protein A silica
24. Effect of HAART on natural history of AIDS-related opportunistic disorders
25. Immune restoration disease in HIV-infected patients after anti-retroviral therapy
26. A possible pathogenic role of CD8+ T cells and their derived cytokine, IL-16, in SLE
27. Virus-induced immune dysregulation as a triggering factor for the development of drug rashes and autoimmune diseases: With emphasis on EB virus, human herpesvirus 6 and hepatitis C virus
28. Pathogenesis of cytomegalovirus infection. Distribution of viral products, immune complexes and autoimmunity during latent murine infection
29. Virus-induced autoimmune disease
30. From infection to autoimmunity
31. B-cell activation following murine cytomegalovirus infection: Implications for autoimmunity
32. Autoimmune response U1 small nuclear ribonucleoprotein (U1 snRNP) associated with cytomegalovirus infection
33. Serum antibodies from patients with primary Sjögren's syndrome and systemic lupus erythematosus recognize multiple epitopes on the La (SS-B) autoantigen resembling viral protein sequences
34. Virus infection induces redistribution and membrane localization of the nuclear antigen La (SS-B): A possible mechanism for autoimmunity
35. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase
36. Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase
37. A novel mechanism for virus-induced autoimmunity in humans
38. Regulation of KIR expression in human T cells: A safety mechanism that may impair protective T-cell responses
39. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo
40. The class I MHC homology of human cytomegalovirus inhibits attack by natural killer cells